Clinical Trial Update: The Role of Amylin and Glucagon in T1DM [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating the roles of amylin and glucagon in Type 1 diabetes mellitus has completed. The update summarizes the trial status and outcomes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• GLUCAGON (GLUCAGON)
• pramlintide (pramlintide)

Snippet

Sponsor: Baylor College of Medicine | Conditions: Type 1 Diabetes | Phase 3 | Status: COMPLETED